Welcome to the Settlement website for the Ra Medical Securities Litigation (the “Action”).
If you purchased or otherwise acquired Ra Medical Common Stock pursuant and/or traceable to Ra Medical's initial public offering and/or between September 27, 2018 and November 27, 2019, inclusive (The Settlement Class Period) you could receive a payment from a class action settlement. Certain persons are excluded from the Settlement Class as set forth in the Notice.
Subject to Court approval, Lead Plaintiffs, on behalf of themselves and the Settlement Class, have agreed to settle the Action in exchange for a settlement payment of $10,000,000 in cash (the “Settlement Amount”) to be deposited into an escrow account. The Net Settlement Fund (i.e., the Settlement Amount plus any and all interest earned thereon (the “Settlement Fund”) less (a) any Taxes, (b) any Notice and Administration Costs, (c) any Litigation Expenses awarded by the Court, and (d) any attorneys’ fees awarded by the Court) will be distributed in accordance with a plan of allocation that is approved by the Court, which will determine how the Net Settlement Fund shall be allocated among members of the Settlement Class. The proposed plan of allocation is included in the Notice.
Your legal rights are affected whether you act or don’t act. Read the Notice carefully.